1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZYG11B CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA ZUFSP CTRPv2 pan-cancer AAC 0.11 0.0007
mRNA ZSWIM5 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA ZSWIM4 CTRPv2 pan-cancer AAC 0.12 0.0001
mRNA ZSCAN23 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA ZSCAN2 CTRPv2 pan-cancer AAC 0.14 6e-05
mRNA ZRANB2 CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA ZPR1 CTRPv2 pan-cancer AAC -0.12 0.0005
mRNA ZNF92 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA ZNF891 CTRPv2 pan-cancer AAC 0.15 2e-05
Download CSV